Mohee, A., Khan, A., Harris, N., & Eardley, I. (2013). Long‐term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB). BJU international, 111(1), 106-113. https://doi.org/10.1111/j.1464-410X.2012.11282.x
Chicago Style (17th ed.) CitationMohee, Amar, Ayisha Khan, Neil Harris, and Ian Eardley. "Long‐term Outcome of the Use of Intravesical Botulinum Toxin for the Treatment of Overactive Bladder (OAB)." BJU International 111, no. 1 (2013): 106-113. https://doi.org/10.1111/j.1464-410X.2012.11282.x.
MLA (9th ed.) CitationMohee, Amar, et al. "Long‐term Outcome of the Use of Intravesical Botulinum Toxin for the Treatment of Overactive Bladder (OAB)." BJU International, vol. 111, no. 1, 2013, pp. 106-113, https://doi.org/10.1111/j.1464-410X.2012.11282.x.